# A Study of Anti-BCMA CAR-T Therapy in Newly Diagnosed Myeloma Patients Who Are Transplant-ineligible

> **NCT07070960** · NA · NOT_YET_RECRUITING · sponsor: **Xuzhou Medical University** · enrollment: 35 (estimated)

## Conditions studied

- Multiple Myeloma
- Newly Diagnosed

## Interventions

- **BIOLOGICAL:** CAR-T

## Key facts

- **NCT ID:** NCT07070960
- **Lead sponsor:** Xuzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-15
- **Primary completion:** 2026-07-15
- **Final completion:** 2028-07-31
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07070960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07070960, "A Study of Anti-BCMA CAR-T Therapy in Newly Diagnosed Myeloma Patients Who Are Transplant-ineligible". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07070960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*